NL-OMON45158已完成4 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantation - POPular-TAVI
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patient has provided written informed consent.;Cohort B
- •1. Need for long-term oral anticoagulation;
- •2. Patient has provided written informed consent.
排除标准
- •1. Need for long-term oral anticoagulation.
- •2. Drug-eluting stent implantation within 3 months prior to TAVI procedure.
- •3. Bare-metal stent implantation within 1 month prior to TAVI procedure.
- •4. Allergy or intolerance or contraindication to aspirin or clopidogrel.;Cohort B
- •1. Drug-eluting stent implantation within 3 months prior to TAVI procedure.
- •2. Bare-metal stent implantation within 1 month prior to TAVI procedure.
- •3. Allergy or intolerance or contraindication to OAC or clopidogrel.
研究者
相似试验
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic stenosis for which a transcatheter aortic valve implantation (TAVI) is performed.MedDRA version: 19.1Level: PTClassification code 10002906Term: Aortic stenosisSystem Organ Class: 10047065 - Vascular disordersEUCTR2013-003125-28-GBSt. Antonius Hospital1,000
招募中
不适用
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic valve diseaseaortic valve stenosisbleedingthrombosisplatelet inhibitors.strokeNL-OMON25546St Antonius Hospital, Nieuwegein, the Netherlands1,000
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioEUCTR2013-003125-28-BESt. Antonius Hospital1,000
进行中（未招募）
1 期
Antiplatelet therapy for patients undergoing transcatheter aortic valve implantatioAortic stenosis for which a transcatheter aortic valve implantation (TAVI) is performed.EUCTR2013-003125-28-NLSt. Antonius Hospital2,200
招募中
不适用
Perioperative Antiplatelet therapy in patients with drug-eluting Stent undergoing noncardiac SURgEryKCT0002907Asan Medical Center1,000